What is the CAGR value of the Gastrointestinal Cancer Drugs Market?
Gastrointestinal Cancer Drugs Market is expected to grow at a CAGR of 5% during the forecast period 2024-2031.
Who are the key players in Gastrointestinal Cancer Drugs Market?
key players are Novartis AG, Amgen, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Johnson & Johnson Private Limited, GlaxoSmithKline plc, Celgene Corporation, Pfizer Inc and Sanofi.